APA (7th ed.) Citation

Trotman, J., Presgrave, P., Carradice, D. P., Lenton, D. S., Gandhi, M. K., Cochrane, T., . . . Johnston, A. M. (2023). Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study. Wiley.

Chicago Style (17th ed.) Citation

Trotman, Judith, et al. Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study. Wiley, 2023.

MLA (9th ed.) Citation

Trotman, Judith, et al. Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study. Wiley, 2023.